Go Pro
→ They didn't warn anyone in 1971. This time someone is warning you. (From Reagan Gold Group) (Ad)tc pixel
LON:HLN

Haleon Final Earnings Report

Haleon logo
GBX 350.20 -5.40 (-1.52%)
As of 12:18 PM Eastern
ProfileEarnings HistoryForecast

Haleon EPS Results

Actual EPS
GBX 15.80
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Haleon Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Haleon Announcement Details

Quarter
Final
Date
2/28/2025
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Haleon Earnings Headlines

Royal Bank Of Canada Raises Haleon (LON:HLN) Price Target to GBX 390
August 13, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30957152
Goldman Sachs Reaffirms Their Buy Rating on Haleon PLC (HLN)
August 11, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/HLN-N/pressreleases/3590295/goldman-sachs-reaffirms-their-buy-rating-on-haleon-plc-hln/
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live.tc pixel
August 17 at 1:00 AM  |  Porter & Company (Ad)
Berenberg Bank Raises Haleon (LON:HLN) Price Target to GBX 514
August 7, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30945739
Haleon Updates Share Capital and Voting Rights Structure
August 3, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/haleon-updates-share-capital-and-voting-rights-structure?utm_source=marketbeat.com&utm_medium=referral
Sensodyne maker Haleon slips as sales growth concerns overshadow profit beat
July 30, 2026  |  reuters.comhttps://www.reuters.com/business/healthcare-pharmaceuticals/sensodyne-maker-haleon-posts-higher-second-quarter-organic-revenue-growth-2026-07-30/
See More Haleon Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Haleon? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Haleon and other key companies, straight to your email.

About Haleon

Haleon (LON:HLN) (LSE / NYSE: HLN) is a world-leading consumer health company, with a clear purpose to deliver better everyday health with humanity. In July 2022, it listed as an independent company on the London and New York Stock Exchanges. Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Its long-standing brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are built on trusted science, innovation and deep human understanding.

View Haleon Profile
Earnings Tools